- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
OPERATION OF IN-HOSPITAL TRANSFUSION IN A CORE MEDICAL AGENCY THAT POSSESSES A MEDICAL EMERGENCY CENTER ON AMAMI OSHIMA
-
- Kiyotake Takako
- Department of Clinical Laboratory, Kagoshima Prefectural Oshima Hospital
-
- Yoshikuni Kenichirou
- Department of Clinical Laboratory, Kagoshima Prefectural Oshima Hospital
-
- Hara Jun
- Department of Emergency Medicine, Kagoshima Prefectural Oshima Hospital
-
- Oki Hiroshi
- Department of Anesthesiology, Kagoshima Prefectural Oshima Hospital
Bibliographic Information
- Other Title
-
- 奄美大島の救命救急センターを保有する中核医療機関における院内血(生血)輸血実施状況について
Search this article
Description
<p>BACKGROUND: Kagoshima Prefectural Oshima Hospital has a critical care center that provides helicopter ambulance services. However, the Japanese Red Cross Society withdrew its branch in the Oshima area in March 2018; therefore, it is important for us in Oshima Hospital to stock up on blood products by ourselves. Further, the donor system for whole blood transfusion (WBT) provided by blood donors for unexpected massive hemorrhage requires investigation.</p><p>MATERIALS and METHODS: From 2014 to 2018, 18 patients received WBT. We retrospectively analyzed the clinical features of the patients.</p><p>RESULTS: Half of the patients received WBT (51%) because of thrombopenia or insufficient platelet products. After WBT, the platelet count and serum fibrinogen ratio were significantly increased in these patients (p<0.01).</p><p>DISCUSSION: While the WBT donor system works well, it is important to consider the safety of this system and to reduce the burden on blood donors.</p><p>CONCLUSION: The platelet count and serum fibrinogen ratio of 18 patients were significantly increased after WBT. We expect that medical insurance will cover the cost of cryoprecipitate or fibrinogen products for massive bleeding.</p>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 66 (1), 13-18, 2020-02-25
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390565134835098112
-
- NII Article ID
- 130007808364
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed